Idefirix Den europeiske union - norsk - EMA (European Medicines Agency)

idefirix

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunsuppressive - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Xenpozyme Den europeiske union - norsk - EMA (European Medicines Agency)

xenpozyme

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - andre alimentary tract and metabolism products, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.

Orfiril 600 mg Norge - norsk - Statens legemiddelverk

orfiril 600 mg

orifarm as - natriumvalproat - enterotablett - 600 mg

Orfiril 600 mg Norge - norsk - Statens legemiddelverk

orfiril 600 mg

orifarm as - natriumvalproat - enterotablett - 600 mg

Orfiril 600 mg Norge - norsk - Statens legemiddelverk

orfiril 600 mg

orifarm as - natriumvalproat - enterotablett - 600 mg

Orfiril 600 mg Norge - norsk - Statens legemiddelverk

orfiril 600 mg

orifarm as - natriumvalproat - enterotablett - 600 mg

Valproat Life Medical 100 mg/ ml Norge - norsk - Statens legemiddelverk

valproat life medical 100 mg/ ml

life medical aps (1) - natriumvalproat - injeksjons-/infusjonsvæske, oppløsning - 100 mg/ ml